Tissue plasminogen activator challenge thrombelastography is the most accurate assay in predicting the need for massive transfusion in hypotensive trauma patients

Am J Surg. 2023 Dec;226(6):778-783. doi: 10.1016/j.amjsurg.2023.05.033. Epub 2023 Jun 2.

Abstract

Background: Tissue plasminogen activator (tPA) added to thrombelastography (TEG) detects hyperfibrinolysis by measuring clot lysis at 30 min (tPA-challenge-TEG). We hypothesize that tPA-challenge-TEG is a better predictor of massive transfusion (MT) than existing strategies in trauma patients with hypotension.

Methods: Trauma activation patients (TAP, 2014-2020) with 1) systolic blood pressure <90 mmHg (early) or 2) those who arrived normotensive but developed hypotension within 1H postinjury (delayed) were analyzed. MT was defined as >10 RBC U/6H postinjury or death within 6H after ≥1 RBC unit. Area under the receiver operating characteristics curves were used to compare predictive performance. Youden index determined optimal cutoffs.

Results: tPA-challenge-TEG was the best predictor of MT in the early hypotension subgroup (N = 212) with positive (PPV) and negative predictive values (NPV) of 75.0%, and 77.6%, respectively. tPA-challenge-TEG was a better predictor of MT than all but TASH (PPV = 65.0%, NPV = 93.3%) in the delayed hypotension group (N = 125).

Conclusions: The tPA-challenge-TEG is the most accurate predictor of MT in trauma patients arriving hypotensive and offers early recognition of MT in patients with delayed hypotension.

Keywords: Coagulopathy; Hemorrhagic shock; Hypotension; Massive transfusion; Resuscitation; Thrombelastography.

MeSH terms

  • Blood Coagulation Disorders* / diagnosis
  • Blood Transfusion
  • Humans
  • Hypotension* / diagnosis
  • Hypotension* / etiology
  • Thrombelastography
  • Tissue Plasminogen Activator
  • Wounds and Injuries* / complications
  • Wounds and Injuries* / therapy

Substances

  • Tissue Plasminogen Activator